CAR-T engineering of patients’ own T cells for cancer therapy gains traction – Genetic Literacy Project
Genetic Literacy Project |
CAR-T engineering of patients’ own T cells for cancer therapy gains traction
Genetic Literacy Project First, Gilead Sciences of Foster City, California, announced plans on August 28 to dole out $11.9 billion to acquire Santa Monica, California–based Kite Pharma, one of the leading developers of chimeric antigen receptor (CAR)-T cell immunotherapies … |
Genetic Literacy Project |
CRISPR 2.0 ‘base editing’ arrives and it’s an even more remarkable …
Genetic Literacy Project You’ve probably heard of the molecular scalpel CRISPR-Cas9, which can edit or delete whole genes. Now, scientists have developed a more precise version of. ALS Research Forum | Scientists Unleash CRISPR on RNAALS Research Forum Genetic diseases: Here is going beyond CRISPR-CAS9 – The …Financial Express |
|
A non-invasive computational imaging approach may predict …
Medical Xpress A computational imaging-based signature of immune-cell infiltration in and around a tumor could predict patients’ responses to treatment with anti-PD1/PDL1 … |